Marissa Plescia is a reporter at MedCity News. She covers a range of topics related to medicine and healthcare, including healthcare administration, public health, and health technology, with a focus on payers, employers, and digital health innovations. Marissa has been featured in notable publications such as LegalTech News, NewsBreak, and Above the Law.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Marissa's coverage primarily revolves around healthcare and pharmaceuticals, with a focus on industry outlooks, reports, and private sector announcements. She is likely to be interested in pitches that offer insights from experts in the healthcare industry, particularly those related to trends such as AI integration, health equity improvement strategies, cost pressures facing healthcare organizations, and innovative care models.
Given her reliance on data and press releases in her coverage attributes, Marissa may be receptive to pitches supported by robust data or involving significant developments within the private sector. Pitches offering expert commentary on emerging trends or analysis of recent reports are likely to resonate well with her.
While there is no specific geographic focus mentioned for Marissa's work, she appears open to covering topics relevant at an international level within the healthcare and pharmaceutical industries.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Marissa Plescia
In this episode, we're joined by Amanda Shafton, practicing CNM and national director of midwifery at Ob Hospitalist Group. We discuss the benefits of physician/midwifery collaboration and how midwives can improve maternal health outcomes.
By: Marissa Plescia
HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and crisis services.
By: Marissa Plescia
Thyme Care's Series E round was led by Morgan Health and included participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures and a16z Bio + Health.
By: Marissa Plescia
Judi Health expanded its healthcare network to offer specialized virtual care for cancer, autoimmune and GI conditions while helping employers reduce overall healthcare costs.
By: Marissa Plescia
Rep. Frank Pallone, Jr., is seeking information from six IDR entities amid concerns about No Surprises Act arbitration practices and rising healthcare costs.
Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Avra, Human Capital, Neo, Vast Ventures and SV Angel.
By: Marissa Plescia
A PHTI analysis found that virtual CKD management programs have little impact on disease progression or healthcare spending and recommends shifting the focus toward earlier diagnosis and treatment.
By: Marissa Plescia
A Georgetown report outlines three strategies to improve health insurance by lowering costs, simplifying coverage and protecting patients from corporate abuses.
By: Marissa Plescia
Flare Capital Partners led the Series A round. Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health Investors and ARTIS also participated.
Interra Health is helping Medicare patients access $50-per-month GLP-1s through the new Bridge program.
